Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

• Ada H. V. Repetto-Llamazares ,

  * E-mail: arepetto@nordicnanovector.com

  Affiliations Nordic Nanovector ASA, Kjelsåsveien 168, 0884, Oslo, Norway, Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway

  ⨯
• Roy H. Larsen,

  Affiliation Sciencons AS, Kjelsåsveien 168, 0884, Oslo, Norway

  ⨯
• Sebastian Patzke,

  Affiliation Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway

  ⨯
• Karianne G. Fleten,

  Affiliation Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway

  ⨯
• David Didierlaurent,

  Affiliation UMR 1037 INSERM/UPS, Centre de Recherche en Cancérologie de Toulouse, Toulouse, F-31062, France

  ⨯
• Alexandre Pichard,

  Affiliation Institut de Recherche en Cancérologie de Montpellier, Institut National de la Santé et de la Recherche Médicale, U896, Université Montpellier, Montpellier, France

  ⨯
• Jean Pierre Pouget,

  Affiliation Institut de Recherche en Cancérologie de Montpellier, Institut National de la Santé et de la Recherche Médicale, U896, Université Montpellier, Montpellier, France

  ⨯
• Jostein Dahle

  Affiliation Nordic Nanovector ASA, Kjelsåsveien 168, 0884, Oslo, Norway

  ⨯